Small-molecule inhibitors of RhoB have not been described, although molecules that target RhoA, Rac and Cdc42 have been (Biro et al., 2014), including Rac inhibitors studied in models of type 1 diabetes and collagen-induced arthritis (Veluthakal et al., 2016). Here, CDC42 is linked to type 1 diabetes mellitus.